F-18 FDG PET in detecting renal cell carcinoma

Acta Radiologica

Volumn 46, Issue 8, 2005, Pages 895-899

  Ak, I ^a   Can, C ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

Coincidence PET; F 18 FDG; Renal cell carcinoma

Indexed keywords

DIAGNOSIS; DISEASES; HISTOLOGY; MEDICAL IMAGING; PATIENT TREATMENT; ULTRASONICS;

COINCIDENCE PET; F-18 FDG; RENAL CELL CARCINOMA;

POLYETHYLENE TEREPHTHALATES;

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

AGED; ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; INSTRUMENTATION; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY; PREDICTION AND FORECASTING; REPRODUCIBILITY; SCINTILLATION CAMERA; SCINTISCANNING;

AGED; CARCINOMA, RENAL CELL; FEMALE; FLUORODEOXYGLUCOSE F18; GAMMA CAMERAS; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS;

EID: 30844450356     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1080/02841850500335002     Document Type: Article

References (27)

1. Ak I, Stokkel M, Pauwels E. Positron emission tomography with 2-(18F)fluoro-2-deoxy-D-glucose in oncology. Part II. The clinical value in detecting and staging primary tumors. J Cancer Res Clin Oncol 2000;126:560-74 (Review).
2. Bachor R, Kotzerke J, Gottfried H, Brandle E, Reske S, Hautmann R. Positron emission tomography in diagnosis of renal cell carcinoma. Urology A 1996;35: 146-50.
3. Boren E, Delbeke D, Ptton J, Sandler M. Comparison of FDG PET and positron coincidence detection imaging using a dual-head gamma camera with 5/8-inch NaI(Tl) crystals in patients with suspected body malignancies. Eur J Nucl Med 1999;26:379-87.
4. Chang C, Wu H, Tsai J, Shen Y, Changlai S, Kao A. Detecting metastasis pelvic lymph nodes by 18F-2-deoxyglucose positron emission tomography in patients with prostate-specific antigen relapse after treatment for localized prostate cancer. Urol Int 2003;70:311-35.
5. Goldberg M, Mayo-Smith W, Papanicolaou N, Fischman A, Lee M. FDG PET characterization of renal masses: preliminary experience. Clin Radiol 1997;52:510-15.
6. Hain S, O'Doherty M, Timothy A, Leslie M, Harper P, Huddart R. Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumors at relapse. Br J Cancer 2000;83:863-9.
7. Hilton S. Imaging of renal cell carcinoma. Semin Oncol 2000;27:150-9.
8. Hofer C, Kubler H, Härtung R, Breul J, Avril N. Diagnosis and monitoring of urological tumors using positron emission tomography. Eur Urol 2001;40:481-7.
9. Hofer C, Laubenbacher C, Block T, Breul J, Hartung R, Schwaiger M. Fluorine-18-fluorodeoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomy. Eur Urol 1999;36:31-5.
10. Jadvar H, Kherbache H, Pinski J, Conti P. Diagnostic role of (F-18)-FDG positron emission tomography in restaging renal cell carcinoma. Clin Nephrol 2003;60: 395-400.
11. Jemal A, Tiwari R, Murray T, Ghafoor A, Samuels A, Ward E, et al. American Cancer Society. Cancer statistics, 2004. CA Cancer J Clin 2004;54:8-29.
12. Kang D, White RL J, Zuger J, Sasser H, Teigland C. Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma. Urol 2004;171:1806-9.
13. Kostakoglu L, Coleman M, Leonard J, Kuji I, Zoe H, Goldsmith S. PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease. J Nucl Med 2002;43:1018-27.
14. Lam J, Shvarts O, Pantuck A. Changing concepts in the surgical management of renal cell carcinoma. Eur Urol 2004;45:692-705.
15. Lanctin H, Futter N. Renal cell carcinoma: incidental detection. Can J Surg 1992;33:488-90.
16. Majhail N, Urbain J, Albani J, Kanvinde M, Rice T, Novick A, et al. F-18 fluorodeoxyglucose positron emission tomography in the evaluation of distant metastases from renal cell carcinoma. J Clin Oncol 2003;21:3995-4000.
17. Mevorach R, Segal A, Tesegno M, Frank I. Renal cell carcinoma: incidental diagnosis and natural history: review of 235 cases. Urology 1992;39:519-22.
18. Miller E, Lerman H, Gutman M, Figer A, Livshitz G, Even-Sapir E. The clinical impact of camera-based positron emission tomography imaging in patients with recurrent colorectal cancer. Invest Radiol 2004;39:8-12.
19. Montravers F, Grahek D, Kerrou K, Younsi N, Doublet J, Gattegno B, et al. Evaluation of FDG uptake by renal malignancies (primary tumor or metastases) using a coincidence detection gamma camera. J Nucl Med 2000;41:78-84.
20. Motzer R. Prognostic factors and clinical trials of new agents in patients with metastatic renal cell carcinoma. Crit Rev Oncol Hematol 2003;27:S33-9.
21. Oyama N, Akino H, Suzuk iY, Kanamaru H, Ishida H, Tanase K, et al. FDG PET for evaluating the change of glucose metabolism in prostate cancer after androgen ablation. Nucl Med Commun 2001;22:963-9.
22. Pantuck A, Zisman A, Belldegrun A. The changing natural history of renal cell carcinoma. J Urol 2001;166:1611-23.
23. Shreve P, Steventon R, Deters E, Kison P, Gross M, Wahl R. Oncologic diagnosis with 2-(fluorine-18)fluoro-2-deoxy-D-glucose imaging: dual-head coincidence gamma camera versus positron emission tomographic scanner. Radiology 1998;207:431-7.
24. Spermon J, De Geus-Oei L, Kiemeney L, Witjes J, Oyen W. The role of (18)fluoro-2-deoxyglucose positron emission tomography in initial staging and re-staging after chemotherapy for testicular germ cell tumours. BJU Int 2002;89:549-56.
25. Stokkel M, Terhaard C, Mertens I, Hordijk G, van Rijk P. Fluorine-18-FDG detection of laryngeal cancer postradiotherapy using dual-head coincidence imaging. J Nucl Med 1998;39:1385-87.
26. Tatsumi M, Yutani K, Watanabe Y, Myoshi S, Tomiyama N, Johkoh T, et al. Feasibility of fluoro-deoxyglucose dualhead gamma camera coincidence imaging in the evaluation of lung cancer: comparison with FDG PET. J Nucl Med 1999;40:566-73.
27. Walter C, Scheidhauer K, Scharl A, Goering U, Theissen P, Kugel H, et al. Clinical and diagnostic value of preoperative MR mammography and FDG-PET in suspicious breast lesions. Eur Radiol 2003; 13:1651-6.